TREM1 and cancer: It should be also noted that in our another study, one of the cancer studies cited [Shen and Sigalov (4) in the paper by Gibot et al. (16)], we used a ligand-independent human TREM-1 inhibitory peptide GFLSKSLVF (GF9), not peptide LR12, to suppress tumor growth and prolong survival of mice with experimental pancreatic cancer (4).